Tech Company Financing Transactions
Cold Genesys Funding Round
Ally Bridge Group joined a $13.6 million Series A funding round for Cold Genesys. The round was recorded on 8/1/2014.
Transaction Overview
Company Name
Announced On
8/1/2014
Transaction Type
Venture Equity
Amount
$13,570,000
Round
Series A
Investors
Ally Bridge Group (Arthur Kuan)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
400 Spectrum Center Dr. 2040
?Irvine, CA 92618
USA
?Irvine, CA 92618
USA
Phone
Undisclosed
Website
Email Address
Overview
Cold Genesys, Inc., a clinical-stage biopharmaceutical company developing oncolytic immunotherapies for cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Arthur Kuan
Chief Scientific Officer
Paola Grandi
Controller
Amy Steele
VP - Bus. Development
Bing Kung
VP - Manufacturing
Bradley Grimm
Browse more venture capital transactions:
Prev: 8/1/2014: Webtalk venture capital transaction
Next: 8/1/2014: BRANDiD venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs